paul.nowak wrote: Matt, thanks for the comments. I made an error on the version of Plone. It's 2.5 Plone running on Zope 2.9x.
In regards to the additional products, we have a skin installed and we have a product that we had custom developed for us that connects to a PostgreSQL database. We've looked at slow PostgreSQL queries causing problems and have not been able to find an issue. We've also tested for the case where the PostgreSQL server is down and have not been able to create an issue. We therefor...
JERUSALEM -- (MARKET WIRE) -- 04/10/07 -- IDenta Corp. (PINKSHEETS: IDTA) released a
memorandum today detailing a number of significant activities the company
will be undertaking in the coming months. The memo lists activities with
the government of France, a U.S. visit by IDenta's CEO along with its Chief
Scientist in early May, the development of a drug detector for morphine,
the completion of testing for two new drug detectors, and applications for
two new U.S. patents.
"It is hard to prioritize the value of these business activities, but do I
feel that this mission to the U.S. may be our most important in a long
time," said Yaacov Shoham, IDTA CEO. "Our marketing channels in the U.S.
are beginning to report sales of drug detectors, as well as a growing
interest in our IDenta Alert explosive detectors. We have scheduled
high-level meetings in each of the cities we are visiting, and expect to
make some very important announcements following this trip."
Significant company activities for the next three months include:
1. United States Marketing Mission -- the current schedule includes
appointments with company representatives and law enforcement agencies in
Orlando, Atlanta, Los Angles and New York.
2. Canada -- A visit to Toronto to finalize an agreement for product
sales and representation.
3. GHB (a.k.a. date rape drugs) detection kits will soon be in
production. The company believes there may be a significant consumer market
for this detector because of the easy and inexpensive ability to detect the
presence of illegal substances in substances such as alcoholic drinks
served in bars and night clubs.
The Ketamine drug detector will also soon be in production.
4. IDenta is expecting to receive patents for several new products
including the GHB kit (drug testing kit) and for TATP (explosive
identifiers). Company testing of the TATP kit indicates it may be the most
advanced, reliable explosive detector kit currently on the market.
5. The French Interior Minister has asked IDenta to develop a new drug
detector for morphine.
6. The Marseille Laboratory in France is currently testing IDenta Alert
explosive identifiers against other competing products. Indications from
the company's representatives in France, IBTEC, indicate that the final
report will be very positive.
Any publication or law enforcement agency interested in speaking directly
with Mr. Shoham while he is in the U.S. may call 800-316-9437 or email him
at fpi@drugsdetector.com.
A teleconference for the press and the investment community has tentatively
been scheduled for May 1st at 9:30 a.m. eastern daylight time.
ABOUT IDENTA
Since 2003, IDenta Corporation has become recognized as a worldwide leader
in the development of proprietary on-site drug detection kits and most
recently explosive detection kits. IDenta develops, manufactures and
distributes products for the both professional and civil markets which
consistently pass the highest qualifications and testing procedures of law
enforcement and security agencies around the world. Information concerning
IDenta's business plan and product line may be found at www.identa.biz and
www.drugsdetector.com.
Certain of the statements contained herein may be, within the meaning of
the federal securities laws, "forward-looking statements" that are subject
to risks and uncertainties that could cause actual results to differ
materially from those described in the forward-looking statements. Such
forward-looking statements involve known and unknown risks, uncertainties
and other factors which may cause the actual results, performance or
achievements of the company to be materially different from any future
results, performance or achievements expressed or implied by such
forward-looking statements. These forward-looking statements are based on
management's expectations as of the date hereof, and the company does not
undertake any responsibility to update any of these statements in the
future.
Contact:
For Investor Relations, lobbying interests or information concerning
IDenta's products internationally contact: